| |
|
|
|
Arcus Biosciences Inc.  
|
|
11.865 0.265 (0.02%) |
02-21 15:01 |
|
Open: |
11.57 |
Pre close: |
11.6 |
Target:
|
14.02
|
|
High: |
12 |
Low: |
11.33 |
Resistance:
|
12.00
14.02
|
|
Volume: |
18,559 |
Market Cap: |
527M |
Support:
|
10.13
 8.98
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
11.43
|
MACD |
MACD(12,26):
|
0.36 |
|
MA(20): |
10.41 |
Signal(12,26,9): |
0.17 |
|
MA(100): |
11.19  |
Stochastic Oscillator |
%K(14,3):
|
82.88 |
|
MA(250): |
0.00 |
%D(3): |
82.33 |
|
Average Volume(K) |
3-Month: |
20628
|
52-Week |
High:
|
19.67 |
|
10-Days: |
5440 |
Low: |
8.57 |
|
RSI |
RSI(14):
|
59.35 |
Change(%): |
-31.2 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-20.6 |
Shares Out. (M) |
44.45 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-17.6 |
Shares Float (M) |
43.82 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.40 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
2532.5 |
% Held by Institutions |
46.70 |
|
Forward EPS |
-1.849 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1337 |
|
Book Value (p.s.) |
1.890 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
6.19 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-20.30 |
P/S |
1575281024.00 |
|
Operating Margin |
-680.50 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
-25.61 |
|
|
|
|
|
|
